Table 1 Outcome of FeLV infection in the two FeLV-exposed blood donors and the ten exposed recipient cats
Group | Cat | Outcome of FeLV exposure | Health status long-term follow-upa | |
|---|---|---|---|---|
Blood donors | A | DP | Regressive infection, provirus-positive | Healthy |
B | DR | Regressive infection, viral plasma RNA- and provirus-positive | †Week 60: reactivation of infection, multicentric T-cell lymphomab | |
Recipients | A | P1 | Progressive infection, persistently p27-positive | †Week 31: non-regenerative anemia (FeLV-C)b |
P2 | Progressive infection, persistently p27-positive | †Week 84: multicentric T-cell lymphomab,c | ||
P3 | Regressive infection, provirus-positive | Week 94: feline lower urinary tract disease (FLUTD) | ||
P4 | Regressive infection, provirus-positive | Healthy | ||
P5 | Regressive infection, provirus-positive | †Week 133: reactivation of infection, multicentric T-cell lymphomab | ||
B | R1 | Regressive infection, provirus-positive | †Week 26: reactivation of infection, multicentric T-cell lymphoma with secondary lymphoblastic leukemiab | |
R2 | Regressive infection, provirus-positive | Healthy | ||
R3 | Regressive infection, provirus-positive | Healthy | ||
R4 | Regressive infection, provirus-positive | †Week 28: multicentric T-cell lymphoma; no reactivation of the infection (p27-negative)b | ||
R5 | Regressive infection, provirus-positive | Healthy |